Clinical Trials Directory

Trials / Conditions / Neoadjuvant Therapies

Neoadjuvant Therapies

7 registered clinical trials studyying Neoadjuvant Therapies — 6 currently recruiting.

StatusTrialSponsorPhase
RecruitingNode-Sparing Low-Dose Radiotherapy Concurrent With Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Local
NCT07279077
Sixth Affiliated Hospital, Sun Yat-sen UniversityPhase 2
RecruitingNode-Sparing Hypofractionated Radiotherapy Plus Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally
NCT07230639
Sixth Affiliated Hospital, Sun Yat-sen UniversityPhase 2
RecruitingNode-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for Mid/Low pMMR/MSS Rectal
NCT06958432
Sixth Affiliated Hospital, Sun Yat-sen UniversityPhase 2 / Phase 3
RecruitingModified Long-Course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for MSS/pMMR High-risk Mid/Low L
NCT06923345
Sixth Affiliated Hospital, Sun Yat-sen UniversityPhase 2
RecruitingSafety and Efficacy Study of Sorbitol With Neoadjuvant Chemotherapy Combined With Tirellizumab (PD-1 Inhibitor
NCT06826079
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyPhase 2 / Phase 3
RecruitingCardenilimab Combined With Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
NCT06165380
Li ZhangPhase 2
UnknownNeoadjuvant Immunotherapy (PD-1 / PD-L1) Combined With Chemotherapy for Locally Advanced Thoracic Esophageal S
NCT05028231
Tongji Hospital—